Apligraf® commercial insurance coverage support.
When it comes to treating VLUs and DFUs, 100% of commercial medical policies cover Apligraf.*1 The commercial payer summary guidelines below show what the policies are for a number of insurance providers.
Commercial insurance coverage
of commercial medical policies cover Apligraf treatment for VLUs and DFUs*1
Commercial payer summary guidelines
Aetna Wound Care Policy #0244
Last Review 01/27/2020
Anthem Medical Coverage Policy #SURG 00011
Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft Tissue Grafting
Last review 11/7/2019
BC/BS Federal Employee Program
Bioengineered Skin and Soft Tissue Substitutes Policy #FEP7.01.113
BC/BS Highmark Commercial Medical Policy—Pennsylvania #S-33-032 & #S-249-004
Last Review 9/2019
Cigna Medical Policy #0068
Tissue-Engineered Skin Substitutes
Last review 2/15/20
Excellus Medical Coverage Policy #7.01.35
Bioengineered Tissue Products for Wound Treatment and Surgical Interventions
Last review 6/20/2019
Humana Medical Policy #HCS-0370-033
Skin and Tissue Substitutes
Last review 1/28/2020
Medica Tissue-Engineered Skin Substitutes for Wound and Surgical Care
United Health Care Commercial Medical Policy #2020T0592G
Ready to help your VLU and DFU patients?
Talk to an Organogenesis Tissue Regeneration Specialist about using Apligraf, the gold standard to heal VLUs and DFUs faster.Contact us
Please refer to the Apligraf Package Insert for complete prescribing information.
- Data on file. Organogenesis Inc.